DaVita HealthCare (DVA) closed at $116.51, up +1.14% from the previous trading day, outperforming the S&P 500. Analysts anticipate a 49.11% increase in EPS and a 6.99% revenue growth. DaVita’s current Forward P/E ratio is 10.95, below the industry average of 19.65. The company holds a Zacks Rank of #3 (Hold).

Zacks experts handpicked 5 stocks expected to double, including disruptive forces, leaders in growing industries, and compelling investments. These stocks offer potential gains of +100% or more. While not all picks may succeed, past recommendations have soared +171%, +209%, and +232%. Get in on the ground floor with these overlooked opportunities.

For more insights and updates on stock-moving metrics, visit Zacks.com during upcoming trading sessions. Consider downloading Zacks Investment Research’s free reports on Atomic Opportunity: Nuclear Energy’s Comeback and 7 Best Stocks for the Next 30 Days. Follow DaVita Inc. (DVA) for free stock analysis and stay informed. Remember, the author’s views do not necessarily reflect those of Nasdaq, Inc.

Read more at Nasdaq: DaVita HealthCare (DVA) Beats Stock Market Upswing: What Investors Need to Know